BCR-ABL delays apoptosis upstream of procaspase-3 activation

Blood

Volumn 91, Issue 7, 1998, Pages 2415-2422

  Dubrez, Laurence ^b   Eymin, Béatrice ^b   Sordet, Olivier ^b   Droin, Nathalie ^b   Turhan, Ali G ^b   Solary, Eric ^a  

^a INSERM   (France)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ETOPOSIDE;

APOPTOSIS; ARTICLE; CHROMOSOME 22Q; CHRONIC MYELOID LEUKEMIA; DNA DEGRADATION; ENZYME ACTIVATION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION;

EID: 0032055535     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v91.7.2415.2415_2415_2422     Document Type: Article

References (46)

1. Nowell PC, Hungerford DA: A minute chromosome in human chronic granulocytic leukemia. Science 132:1497, 1960
2. Ben-Neriah Y, Daley QG, Mes-Mason AM, Witte ON, Baltimore D: The chronic myelogenous leukemia-specific p210 protein is the product of the bcr-abl hybrid gene. Science 233:212, 1986
3. Daley GQ, Van Etten RA, Baltimore D: Induction of chronic myelogenous leukemia in mice by the P210bcr/abl gene of the Philadelphia chromosome. Science 247:824, 1990
4. Eaves AC, Cashman JD, Gaboury LA, Kalousek DK, Eaves CJ: Unregulated proliferation of primitive chronic myelogenous leukemia progenitors in the presence of normal marrow adherent cells. Proc Natl Acad Sci USA 83:5306, 1986
5. Stryckmans P, Debussher L, Socquet M: Regulation of bone marrow myeloblast proliferation in chronic myeloid leukemia. Cancer Res 36:3034, 1976
6. Spooncer E, Fairbairn L, Cowling GJ, Dexter TM, Whetton AD, Owen-Lynch PJ: Biological consequences of p160v-abl protein tyrosine kinase activity in a primitive, multipotent hematopoietic cell line. Leukemia 8:620, 1994
7. Chapman RS, Whetton AD, Dive C: The suppression of drug-induced apoptosis by activation of v-abl protein tyrosine kinase. Cancer Res 54:5131, 1994
8. Bedi A, Zehnbauer BA, Barber JP, Sharkis SJ, Jones RJ: Inhibition of apoptosis by BCR-ABL in chronic myelogenous leukemia. Blood 83:2038, 1994
9. Bedi A, Berber JP, Bedi GC, el-Deiry WS, Sidransky D, Vala MS, Akhtar AJ, Hilton J, Jones RJ: BCR-ABL-mediated inhibition of apoptosis with delay of G2/M transition after DNA damage: A mechanism of resistance to multiple anticancer agents. Blood 86:1148, 1995
10. McGahon A, Bissonnette R, Schmitt M, Cotter KM, Green DR, Cotter TG: BCR-ABL maintains resistance of chronic myelogenous leukemia cells to apoptotic cell death. Blood 83:1179, 1994
11. Laneuville P, Timm M, Hudson AT: Bcr/abl expression in 32D c13(G) cells inhibits apoptosis induced by protein tyrosine kinase inhibitors. Cancer Res 54:1360, 1994
12. McGahon AJ, Nishioka WK, Martin SJ, Mahboubi A, Cotter TG, Green DR: Regulation of the Fas apoptotic cell death pathway by Abl. J Biol Chem 270:22625, 1995
13. Smetsers TF, van de Locht LTF, Pennings AH, Wessels HM, de Witte T, Mensink EJ: Phosphorothioate BCR-ABL antisense oligonucleotides induce cell death, but fail to reduce cellular bcr-abl protein levels. Leukemia 8:129, 1994
14. Evans CA, Lord JM, Owen-Lynch PJ, Johnson G, Dive C, Whetton AD: Suppression of apoptosis by v-ABL protein tyrosine kinase is associated with nuclear translocation and activation of protein kinase C in an iterleukin-3-dependent haematopoietic cell line. J Cell Sci 108:2591, 1995
15. Kan O, Baldwin SA, Whetton AD: Apoptosis is regulated by the rate of glucose transport in an interleukin 3 dependent cell line. J Exp Med 180:917, 1994
16. Cortez D, Stoica G, Pierce JH, Pendergast AM: The BCR-ABL tyrosine kinase inhibits apoptosis by activating a Ras-dependent signaling pathway. Oncogene 13:2589, 1996
17. Owen-Lynch PJ, Wong AK, Whetton AD: V-Abl-mediated apoptotic suppression is associated with SHC phosphorylation without concomitant mitogen-activated protein kinase activation. J Biol Chem 270:5956, 1995
18. Alnemri ES, Livingston DJ, Nicholson DW, Salvesen G, Thornberry NA, Wong WW, Yuan J: Human ICE/CED-3 protease nomenclature. Cell 87:171, 1996
19. Patel T, Gores GJ, Kaufmann SH: The role of proteases during apoptosis. FASEB J 10:587, 1996
20. Kuida K, Lippke JA, Ku G, Harding MW, Livingston DJ, Su MS, flavell RA: Altered cytokine export and apoptosis in mice deficient in interleukin-1β-converting enzyme. Science 267:2000, 1995
21. Dubrez L, Savoy I, Hammann A, Solary E: Pivotal role of a DEVD-sensitive step in etoposide-induced and Fas-mediated apoptotic pathways. EMBO J 15:5504, 1996
22. Fernandes-Alnemri T, Litwack G, Alnemri ES: Mch2, a new member of apoptotic Ced-3/Ice cysteine protease gene family. Cancer Res 55:273, 1995
23. Femandes-Alnemri T, Takahashi A, Armstrong R, Krebs J, Fritz L, Tomaselli KJ, Wang L, Yu Z, Croce CM, Salveson G, Earnshaw WC, Litwack G, Alnemri ES: Mch3, a novel human apoptotic cysteine protease highly related to CPP32. Cancer Res 55:6045, 1995
24. Nicholson DW, Ali A, Thornberry NA, Vaillancourt JP, Ding CK, Gallant M, Gareau Y, Griffin PR, Labelle M, Lazebnik YA, Munday NA, Raju SM, Smulson ME, Yamin T, Yu VL, Miller DK: Identification and inhibition of the ICE/CED-3 protease necessary for mammalian apoptosis. Nature 376:37, 1995
25. Susin SA, Zamzami N, Castedo M, Hirsch T, Marchetti P, Macho A, Daugas E, Geuskens M, Kroemer G: Bcl-2 inhibits the mitochondrial release of an apoptogenic protease. J Exp Med 184:1331, 1996
26. Goldstein P: Controlling cell death. Science 275:1081, 1997
27. Pommier Y, Leteurtre F, Fesen M, Fujimori A, Bertrand R, Solary E, Kohlhagen G, Kohn KW: Cellular determinants of sensitivity and resistance to DNA topoisomerase inhibitors. Cancer Invest 12:530, 1994
28. Dubrez L, Goldwasser F, Genne P, Pommier Y, Solary E: The role of cell cycle regulation and apoptosis triggering in determining the sensitivity of leukemic cells to topoisomerase I and II inhibitors. Leukemia 9:1013, 1995
29. Roger R, Issaad C, Pallardy M, Leglise MC, Turhan AG, Bertoglio J, Breard J: BCR-ABL does not prevent apoptotic cell death induced by human natural killer or lymphokine-activated killer cells. Blood 87:1113, 1996
30. Solary E, Bertrand R, Kohn K, Pommier Y: Differential induction of apoptosis in undifferentiated and differentiated HL60 cells by DNA topoisomerase I and II inhibitors. Blood 81:1359, 1993
31. Smith PK, Krohn RI, Hermanson GT, Mallia AK, Grtner FH, Provenzano MD, Fujimoto EK, Goeke NM, Olson BJ, Klenk DC: Measurement of protein using bicinchoninic acid. Anal Biochem 150:76, 1985
32. Bertrand R, Kohn KW, Solary E, Pommier Y: Detection of apoptosis-associated DNA fragmentation using a rapid and quantitative filter binding assay. Drug Develop Res 34:138, 1995
33. Miller SA, Dykes DD, Polesky HF: A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res 16:1215, 1988
34. Schlegel J, Peters I. Orrenius S, Miller DK, Thornberry NA, Yamin T, Nicholson DW: CPP32/Apopain is a key interleukin 1β converting enzyme-like protease involved in Fas-mediated apoptosis. J Biol Chem 271:1841, 1996
35. Korsmeyer S: Bcl-2 initiates a new category of oncogenes: Regulators of cell death. Blood 80:879, 1992
36. Fisher TC, Milner AE, Gregory CD, Jackman AL, Aherne GW, Hartley JA, Dive C, Hickman JA: Bcl-2 modulation of apoptosis induced by anticancer drugs: Resistance to thymidilate stress is independent of classical resistance pathways. Cancer Res 53:3321, 1993
37. Kaufmann SH, Desnoyers S, Ottaviano Y, Davidson NE, Poirier GG: Specific proteolytic cleavage of poly(ADP-ribose) polymerase: An early marker of chemotherapy-induced apoptosis. Cancer Res 53:3976, 1993
38. Solary E, Dubrez L, Eymin B: The role of apoptosis in the pathogenesis and treatment of diseases. Eur Respir J 9:1293, 1996
39. Green DR, McGahon A, Martin SJ: Regulation of apoptosis by oncogenes. J Cell Biochem 60:33, 1996
40. Chapman RS, Whetton AD, Chresta CM, Dive C: Characterization of drug resistance mediated via the suppression of apoptosis by Abelson protein tyrosine kinase. Mol Pharmacol 48:334, 1995
41. Lotem J, Sachs L: Hematopoietic cytokines inhibit apoptosis induced by transforming growth factor β1 and cancer chemotherapy compounds in myeloid leukemic cells. Blood 80:1750, 1992
42. Enari M, Taianian RV, Wong WW, Nagata S: Sequential activation of ICE-like and CPP32-like proteases during Fas-mediated apoptosis. Nature 380:723, 1996
43. Gu Y, Sarnecki C, Aldape RA, Livingston DJ, Su MSS: Cleavage of Poly(ADP-ribose)polymerase by interleukin-1β converting enzyme and its homologs Tx and Nedd-2. J Biol Chem 32:18715, 1995
44. Fuchs EJ, Bedi A, Jones RJ, Hess AD: Cytotoxic T cells overcome BCR-ABL-mediated resistance to apoptosis. Cancer Res 55:463, 1995
45. Darmon AJ, Nicholson DW, Bleackley RC: Activation of the apoptotic protease CPP32 by cytotoxic T-cell-derived granzyme B. Nature 377:446, 1995
46. Skorski T, Nieborowska-Skorska M, Barletta C, Malaguarnera L, Szczylik C, Chen TS, Lange B, Calabretta B: Highly efficient elimination of Philadelphia leukemic cells by exposure to bcr/abl antisense oligonucleotides combined with mafosfamide. J Clin Invest 92:194, 1993